FBXO32 and sarcopenia: These findings suggest that beLP-K modulates the expression of FoxO3α under DEX-induced cellular damage, which is potentially associated with decreased expression of the E3-ubiquitin ligases MAFbx/atrogin-1 and MuRF1, thereby mitigating muscle proteolysis and alleviating GC-induced sarcopenia.